GlassScriptPhysician profile
Mosi Kadin Bennett
NPI 1396881181
$182,844.31
in general payments reported to CMS, 2019-2025
17 companies · $97K in 2025
The $97K reported for 2025 was more than what 97% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,979 · 2020: $13K · 2021: $11K · 2022: $16K · 2023: $22K · 2024: $15K · 2025: $97K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $97K · Travel and Lodging: $19K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $6,969 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $97,402.94 |
| Travel and Lodging | $18,813.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,000.00 |
| Food and Beverage | $6,969.07 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $109,725.42 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, 2nd Gen Centrimag Primary Console |
| Endotronix, INC. | $36,474.92 | 2021-2025 | Cordella Pulomonary Artery Pressure Sensor, Cordella Pulmonary Artery Pressure Sensor |
| Abiomed | $11,722.31 | 2024-2025 | Impella |
| Cvrx, INC. | $11,532.84 | 2023-2025 | Barostim Neo System |
| Medtronic, INC. | $11,404.50 | 2021-2025 | Micra, Linq II |
| Medtronic Vascular, INC. | $1,203.66 | 2020 | |
| Impulse Dynamics (USA) INC. | $310.40 | 2023 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $145.07 | 2023-2025 | Lifevest |
| Zoll Respicardia, INC. | $127.34 | 2019-2023 | Remede System |
| Itamar Medical INC | $120.86 | 2025 | Watchpatone |
| Bridgebio Pharma, INC. | $22.37 | 2025 | Attruby |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.84 | 2023 | Jardiance |
| Merck Sharp & Dohme LLC | $18.09 | 2024 | Verquvo |
| Novartis Pharmaceuticals Corporation | $14.69 | 2025 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mosi Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.